Wiering Bianca, de Boer Dolf, Delnoij Diana
Tranzo (Scientific Centre for Transformation in Care and Welfare), Tilburg University, Tilburg, The Netherlands.
NIVEL (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Health Expect. 2017 Feb;20(1):11-23. doi: 10.1111/hex.12442. Epub 2016 Feb 18.
Patient-reported outcome measures (PROMs) measure patients' perspectives on health outcomes and are increasingly used in health care. To capture the patient's perspective, it is essential that patients are involved in PROM development OBJECTIVE: This article reviews in what ways and to what extent patients are involved in PROM development and whether patient involvement has increased over time.
Literature was searched in PubMed, EMBASE, MEDLINE and the Cochrane Methodology Register.
Studies were included if they described a new PROM development.
Basic information and information regarding patient involvement in development phases was recorded.
A total of 189 studies, describing the development of 193 PROMs, were included. Most PROMs were meant for chronic disease patients (n = 59) and measured quality of life (n = 28). In 25.9% of the PROM development studies, no patients were involved. Patients were mostly involved during item development (58.5%), closely followed by testing for comprehensibility (50.8%), while patient involvement in determining which outcome to measure was minimal (10.9%). Some patient involvement took place in the development of most PROMs, but in only 6.7% patients were involved in all aspects of the development. Patient involvement did not increase with time.
Although patient involvement in PROM development is essential to develop valid patient-centred PROMs, patients are not always involved. When patients are involved, their level of involvement varies considerably. These variations suggest that further attention to building and/or disseminating consensus on requirements for patient involvement in PROM development is necessary.
患者报告结局测量(PROMs)用于衡量患者对健康结局的看法,在医疗保健中使用得越来越频繁。为了获取患者的观点,患者参与PROM的开发至关重要。
本文回顾了患者以何种方式、在多大程度上参与PROM的开发,以及患者的参与度是否随时间有所增加。
在PubMed、EMBASE、MEDLINE和Cochrane方法学注册库中检索文献。
纳入描述新的PROM开发的研究。
记录基本信息以及患者在开发阶段参与情况的信息。
共纳入189项描述193种PROM开发的研究。大多数PROM针对慢性病患者(n = 59),并用于测量生活质量(n = 28)。在25.9%的PROM开发研究中,没有患者参与。患者大多在条目开发阶段参与(58.5%),其次是可理解性测试(50.8%),而患者在确定测量何种结局方面的参与度最低(10.9%)。大多数PROM的开发过程中都有患者参与,但只有6.7%的研究中患者参与了开发的各个方面。患者参与度并未随时间增加。
尽管患者参与PROM开发对于制定有效的以患者为中心的PROM至关重要,但患者并非总是参与其中。当患者参与时,他们的参与程度差异很大。这些差异表明,有必要进一步关注就患者参与PROM开发的要求建立和/或传播共识。